The Alzheimer’s Disease (AD) Panel is designed for an easy assessment and monitorization of the primary molecular characteristics of Alzheimer’s disease, covering clinically relevant standard genes.
This panel will allow you to perform gene expression studies, relevant for translational research, in a more reproducible and rapid manner. You will be able to evaluate AD phenotypes and disease progression in murine models and in human tissue samples. In addition, you will be able to perform functional screenings of potential therapies.
It includes 770 genes (request list) specific for AD studies, including 23 neurodegeneration pathways and processes.
For more information about the pathways and processes included in the panel, please, consult the product file you can download below.
Advanced Analysis Modules available for this panel:
- Normalization
- Quality Control
- Pathway Analysis
- Differential Expression
- Gene Set Analysis
- Built-in Compatibility for Panel Plus and Protein Analysis
Panel Customization
The Alzheimer’s Disease Panel could be combined with a Panel Plus, which will allow you to add up to 55 genes chosen by the client.
If you want to check that this panel is the most suitable for you, you can go to the NanoString Panel Pro panel selection tool:
